Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Endocrinology | Oncology | Conference News

Back to Journal Articles

ATA: Thyroid Cancer Presents at More Advanced Stage in Poor

Last Updated: September 24, 2012.

 

Individuals in lowest quintile of socioeconomic status have increased odds of advanced cancer

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The odds of presenting with thyroid cancer at an advanced stage are increased for those with low socioeconomic status, but seem to be decreasing slightly over time, according to a study presented at the annual meeting of the American Thyroid Association, held from Sept. 19 to 23 in Montreal.

MONDAY, Sept. 24 (HealthDay News) -- The odds of presenting with thyroid cancer at an advanced stage are increased for those with low socioeconomic status, but seem to be decreasing slightly over time, according to a study presented at the annual meeting of the American Thyroid Association (ATA), held from Sept. 19 to 23 in Montreal.

Stan Van Uum, M.D., Ph.D., from the University of Western Ontario in London, Canada, and colleagues examined the correlation between socioeconomic status and the stage of thyroid cancer at presentation using data from the Canadian Thyroid Cancer Consortium for patients who presented with documented thyroid cancer between January 1998 and December 2010. Socioeconomic data were assigned from the Canadian Census of Population for 1,334 patients.

The researchers found that the odds of a more advanced stage of thyroid cancer at presentation were increased for the lowest socioeconomic status quintile (odds ratio [OR], 1.718); for male versus female gender (OR, 2.077); and for advanced age (OR, 1.010; 95 percent confidence interval [CI], 1.00 to 1.02). Compared with the baseline year, there was a decrease in the odds of advanced stage at presentation for each year (OR, 0.962; 95 percent CI, 0.93 to 1.00).

"Socioeconomic status is an important health indicator for a number of cancers and other diseases. These new data shed light on yet another area -- the time of thyroid cancer diagnoses -- in which there is a need to close [the] gap on this disparity," Elizabeth Pearce, M.D., program co-chair of the annual ATA meeting, said in a statement.

Abstract No. Poster 90
More Information

Copyright © 2012 HealthDay. All rights reserved.


Previous: ATA: Mutation in X-Linked Gene Tied to Central Hypothyroidism Next: Surveillance for Low-Risk Prostate Cancer Examined

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.